Company News
Shukra Pharmaceuticals Issues Name Change Corrigendum
Issued corrigendum to replace original auditor certificate with revised version containing detailed numerical parameters.
Revised certificate shows 100% revenue from pharmaceuticals, 0% from medtech,
